Journal of Shanghai Jiao Tong University (Medical Science) ›› 2022, Vol. 42 ›› Issue (5): 673-679.doi: 10.3969/j.issn.1674-8115.2022.05.017
• Review • Previous Articles Next Articles
ZHAO Min(), CHU Yimin, PENG Haixia()
Received:
2022-02-18
Accepted:
2022-05-25
Online:
2022-05-28
Published:
2022-05-28
Contact:
PENG Haixia
E-mail:15836081368@163.com;phx1101@shtrhospital.com
Supported by:
CLC Number:
ZHAO Min, CHU Yimin, PENG Haixia. Research advances in screening modalities for colorectal cancer and colorectal adenoma[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(5): 673-679.
Add to citation manager EndNote|Ris|BibTeX
URL: https://xuebao.shsmu.edu.cn/EN/10.3969/j.issn.1674-8115.2022.05.017
1 | SUNG H, FERLAY J, SIEGEL R L, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. |
2 | CAO W, CHEN H D, YU Y W, et al. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020[J]. Chin Med J (Engl), 2021, 134(7): 783-791. |
3 | HANG D, JOSHI A D, HE X, et al. Colorectal cancer susceptibility variants and risk of conventional adenomas and serrated polyps: results from three cohort studies[J]. Int J Epidemiol, 2020, 49(1): 259-269. |
4 | BUCCAFUSCA G, PROSERPIO I, TRALONGO A C, et al. Early colorectal cancer: diagnosis, treatment and survivorship care[J]. Crit Rev Oncol Hematol, 2019, 136: 20-30. |
5 | MILETTE S, SICKLICK J K, LOWY A M, et al. Molecular pathways: targeting the microenvironment of liver metastases[J]. Clin Cancer Res, 2017, 23(21): 6390-6399. |
6 | 国家消化系统疾病临床医学研究中心, 国家消化道早癌防治中心联盟, 中华医学会消化内镜学分会, 等. 中国早期结直肠癌筛查流程专家共识意见(2019,上海)[J]. 中华内科杂志, 2019, 58(10): 736-744. |
NATIONAL CLINICAL RESEARCH CENTER FOR DIGESTIVE DISEASES (SHANG HAI), NATIONAL EARLY GASTROINTESTINAL-CANCER PREVENTION & TREATMENT CENTER ALLIANCE (GECA), CHINESE SOCIETY OF DIGESTIVE ENDOSCOPY, et al. Chinese consensus of early colorectal cancer screening (2019, Shanghai) [J]. Chin J Intern Med, 2019, 58(10): 736-744. | |
7 | CARROLL M R, SEAMAN H E, HALLORAN S P. Tests and investigations for colorectal cancer screening[J]. Clin Biochem, 2014, 47(10-11): 921-939. |
8 | ZAUBER A G, WINAWER S J, O'BRIEN M J, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths[J]. N Engl J Med, 2012, 366(8): 687-696. |
9 | BINEFA G, RODRÍGUEZ-MORANTA F, TEULE A, et al. Colorectal cancer: from prevention to personalized medicine[J]. World J Gastroenterol, 2014, 20(22): 6786-6808. |
10 | RABENECK L, RUMBLE R B, THOMPSON F, et al. Fecal immunochemical tests compared with guaiac fecal occult blood tests for population-based colorectal cancer screening[J]. Can J Gastroenterol, 2012, 26(3): 131-147. |
11 | LEE J K, LILES E G, BENT S, et al. Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis[J]. Ann Intern Med, 2014, 160(3): 171. |
12 | SELBY K, LEVINE E H, DOAN C, et al. Effect of sex, age, and positivity threshold on fecal immunochemical test accuracy: a systematic review and meta-analysis[J]. Gastroenterology, 2019, 157(6): 1494-1505. |
13 | ROBERTSON D J, LEE J K, BOLAND C R, et al. Recommendations on fecal immunochemical testing to screen for colorectal neoplasia: a consensus statement by the US multi-society task force on colorectal cancer[J]. Gastroenterology, 2017, 152(5): 1217-1237.e1213. |
14 | YOUNG G P, RABENECK L, WINAWER S J. The global paradigm shift in screening for colorectal cancer[J]. Gastroenterology, 2019, 156(4): 843-851.e842. |
15 | HUANG Y, LI Q, GE W, et al. Predictive power of quantitative and qualitative fecal immunochemical tests for hemoglobin in population screening for colorectal neoplasm[J]. Eur J Cancer Prev, 2014, 23(1): 27-34. |
16 | IMPERIALE T F, GRUBER R N, STUMP T E, et al. Performance characteristics of fecal immunochemical tests for colorectal cancer and advanced adenomatous polyps: a systematic review and meta-analysis[J]. Ann Intern Med, 2019, 170(5): 319-329. |
17 | HAUG U, KNUDSEN A B, LANSDORP-VOGELAAR I, et al. Development of new non-invasive tests for colorectal cancer screening: the relevance of information on adenoma detection[J]. Int J Cancer, 2015, 136(12): 2864-2874. |
18 | IMPERIALE T F, KAHI C J. Cost-effectiveness of future biomarkers for colorectal cancer screening: quantified futility or call for innovation?[J]. Clin Gastroenterol Hepatol, 2018, 16(4): 483-485. |
19 | LANSDORP-VOGELAAR I, GOEDE S L, BOSCH L J W, et al. Cost-effectiveness of high-performance biomarker tests vs fecal immunochemical test for noninvasive colorectal cancer screening[J]. Clin Gastroenterol Hepatol, 2018, 16(4): 504-512.e511. |
20 | AHLQUIST D A, SKOLETSKY J E, BOYNTON K A, et al. Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel[J]. Gastroenterology, 2000, 119(5): 1219-1227. |
21 | IMPERIALE T F, RANSOHOFF D F, ITZKOWITZ S H, et al. Multitarget stool DNA testing for colorectal-cancer screening[J]. N Engl J Med, 2014, 370(14): 1287-1297. |
22 | MU J, HUANG Y, CAI S, et al. Plausibility of an extensive use of stool DNA test for screening advanced colorectal neoplasia[J]. Clin Chim Acta, 2020, 501: 42-47. |
23 | PATEL S S, KILGORE M L. Cost effectiveness of colorectal cancer screening strategies[J]. Cancer Control, 2015, 22(2): 248-258. |
24 | WONG S H, KWONG T N Y, CHOW T C, et al. Quantitation of faecal Fusobacterium improves faecal immunochemical test in detecting advanced colorectal neoplasia[J]. Gut, 2017, 66(8): 1441-1448. |
25 | LIU K, YANG X, ZENG M, et al. The role of fecal Fusobacterium nucleatum and pks(+) Escherichia coli as early diagnostic markers of colorectal cancer[J]. Dis Markers, 2021, 2021: 1171239. |
26 | KIM Y C, KIM J H, CHEUNG D Y, et al. The usefulness of a novel screening kit for colorectal cancer using the immunochromatographic fecal tumor M2 pyruvate kinase test[J]. Gut Liver, 2015, 9(5): 641-648. |
27 | SPADA C, HASSAN C, BELLINI D, et al. Imaging alternatives to colonoscopy: CT colonography and colon capsule. European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastrointestinal and Abdominal Radiology (ESGAR) Guideline-Update 2020[J]. Endoscopy, 2020, 52(12): 1127-1141. |
28 | MARTÍN-LÓPEZ J E, BELTRÁN-CALVO C, RODRÍGUEZ-LÓPEZ R, et al. Comparison of the accuracy of CT colonography and colonoscopy in the diagnosis of colorectal cancer[J]. Colorectal Dis, 2014, 16(3): O82-89. |
29 | LIN O S, KOZAREK R A, GLUCK M, et al. Preference for colonoscopy versus computerized tomographic colonography: a systematic review and meta-analysis of observational studies[J]. J Gen Intern Med, 2012, 27(10): 1349-1360. |
30 | KAWASAKI K, NAKAMURA S, EIZUKA M, et al. Is barium enema examination negligible for the management of colorectal cancer? Comparison with conventional colonoscopy and magnifying colonoscopy[J]. Jpn J Radiol, 2021, 39(12): 1159-1167. |
31 | LEE K L, CHIU N C, SU C W, et al. Less barium enema, more colonoscopy: a 12-year nationwide population-based study in Taiwan[J]. J Chin Med Assoc, 2019, 82(4): 312-317. |
32 | MAASER C, STURM A, VAVRICKA S R, et al. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: initial diagnosis, monitoring of known IBD, detection of complications[J]. J Crohns Colitis, 2019, 13(2): 144-164. |
33 | BALTES P, BOTA M, ALBERT J, et al. PillCamColon2 after incomplete colonoscopy - a prospective multicenter study[J]. World J Gastroenterol, 2018, 24(31): 3556-3566. |
34 | SPADA C, HASSAN C, BARBARO B, et al. Colon capsule versus CT colonography in patients with incomplete colonoscopy: a prospective, comparative trial[J]. Gut, 2015, 64(2): 272-281. |
35 | REX D K, ADLER S N, AISENBERG J, et al. Accuracy of capsule colonoscopy in detecting colorectal polyps in a screening population[J]. Gastroenterology, 2015, 148(5): 948-957.e942. |
36 | GROBBEE E J, VAN DER VLUGT M, VAN VUUREN A J, et al. Diagnostic yield of one-time colonoscopy vs one-time flexible sigmoidoscopy vs multiple rounds of mailed fecal immunohistochemical tests in colorectal cancer screening[J]. Clin Gastroenterol Hepatol, 2020, 18(3): 667-675.e661. |
37 | HOLME Ø, LØBERG M, KALAGER M, et al. Long-term effectiveness of sigmoidoscopy screening on colorectal cancer incidence and mortality in women and men: a randomized trial[J]. Ann Intern Med, 2018, 168(11): 775-782. |
38 | ATKIN W, WOOLDRAGE K, PARKIN D M, et al. Long term effects of once-only flexible sigmoidoscopy screening after 17 years of follow-up: the UK Flexible Sigmoidoscopy Screening randomised controlled trial[J]. Lancet, 2017, 389(10076): 1299-1311. |
39 | LI W, ZHANG L, HAO J, et al. Validity of APCS score as a risk prediction score for advanced colorectal neoplasia in Chinese asymptomatic subjects: a prospective colonoscopy study[J]. Medicine (Baltimore), 2016, 95(41): e5123. |
40 | BRENNER H, STOCK C, HOFFMEISTER M. Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies[J]. BMJ, 2014, 348: g2467. |
41 | SHARAF R N, LADABAUM U. Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies[J]. Am J Gastroenterol, 2013, 108(1): 120-132. |
42 | HADJIPETROU A, ANYFANTAKIS D, GALANAKIS C G, et al. Colorectal cancer, screening and primary care: a mini literature review[J]. World J Gastroenterol, 2017, 23(33): 6049-6058. |
43 | KAMINSKI M F, ROBERTSON D J, SENORE C, et al. Optimizing the quality of colorectal cancer screening worldwide[J]. Gastroenterology, 2020, 158(2): 404-417. |
44 | YAMADA T, MATSUDA A, KOIZUMI M, et al. Liquid biopsy for the management of patients with colorectal cancer[J]. Digestion, 2019, 99(1): 39-45. |
45 | NORMANNO N, CERVANTES A, CIARDIELLO F, et al. The liquid biopsy in the management of colorectal cancer patients: current applications and future scenarios[J]. Cancer Treat Rev, 2018, 70: 1-8. |
46 | SYMONDS E L, COCK C, MENG R, et al. Uptake of a colorectal cancer screening blood test in people with elevated risk for cancer who cannot or will not complete a faecal occult blood test[J]. Eur J Cancer Prev, 2018, 27(5): 425-432. |
47 | GRILLET F, BAYET E, VILLERONCE O, et al. Circulating tumour cells from patients with colorectal cancer have cancer stem cell hallmarks in ex vivo culture[J]. Gut, 2017, 66(10): 1802-1810. |
48 | TSAI W S, YOU J F, HUNG H Y, et al. Novel circulating tumor cell assay for detection of colorectal adenomas and cancer[J]. Clin Transl Gastroenterol, 2019, 10(10): e00088. |
49 | SCHWARZENBACH H, HOON D S, PANTEL K. Cell-free nucleic acids as biomarkers in cancer patients[J]. Nat Rev Cancer, 2011, 11(6): 426-437. |
50 | KHAKOO S, GEORGIOU A, GERLINGER M, et al. Circulating tumour DNA, a promising biomarker for the management of colorectal cancer[J]. Crit Rev Oncol Hematol, 2018, 122: 72-82. |
51 | SPINDLER K L, PALLISGAARD N, ANDERSEN R F, et al. Circulating free DNA as biomarker and source for mutation detection in metastatic colorectal cancer[J]. PLoS One, 2015, 10(4): e0108247. |
52 | DING Y, LI W, WANG K, et al. Perspectives of the application of liquid biopsy in colorectal cancer[J]. Biomed Res Int, 2020, 2020: 6843180. |
53 | REINERT T, SCHØLER L V, THOMSEN R, et al. Analysis of circulating tumour DNA to monitor disease burden following colorectal cancer surgery[J]. Gut, 2016, 65(4): 625-634. |
54 | BETTEGOWDA C, SAUSEN M, LEARY R J, et al. Detection of circulating tumor DNA in early- and late-stage human malignancies[J]. Sci Transl Med, 2014, 6(224): 224ra224. |
55 | LUO H, ZHAO Q, WEI W, et al. Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancer[J]. Sci Transl Med, 2020, 12(524): eaax7533. |
56 | MARCUELLO M, VYMETALKOVA V, NEVES R P L, et al. Circulating biomarkers for early detection and clinical management of colorectal cancer[J]. Mol Aspects Med, 2019, 69: 107-122. |
57 | SONG L, JIA J, PENG X, et al. The performance of the SEPT9 gene methylation assay and a comparison with other CRC screening tests: a meta-analysis[J]. Sci Rep, 2017, 7(1): 3032. |
58 | HU J, HU B, GUI Y C, et al. Diagnostic value and clinical significance of methylated SEPT9 for colorectal cancer: a meta-analysis[J]. Med Sci Monit, 2019, 25: 5813-5822. |
59 | HE N, SONG L, KANG Q, et al. The pathological features of colorectal cancer determine the detection performance on blood ctDNA[J]. Technol Cancer Res Treat, 2018, 17: 1533033818791794. |
60 | FERNÁNDEZ-LÁZARO D, GARCÍA HERNÁNDEZ J L, GARCÍA A C, et al. Liquid biopsy as novel tool in precision medicine: origins, properties, identification and clinical perspective of cancer's biomarkers[J]. Diagnostics (Basel), 2020, 10(4): 215. |
61 | MELTZER P S. Cancer genomics: small RNAs with big impacts[J]. Nature, 2005, 435(7043): 745-746. |
62 | ZUO Z, JIANG Y, ZENG S, et al. The value of microRNAs as the novel biomarkers for colorectal cancer diagnosis: a meta-analysis[J]. Pathol Res Pract, 2020, 216(10): 153130. |
63 | YAN L, ZHAO W, YU H, et al. A comprehensive meta-analysis of microRNAs for predicting colorectal cancer[J]. Medicine (Baltimore), 2016, 95(9): e2738. |
64 | JELSKI W, MROCZKO B. Biochemical markers of colorectal cancer-present and future[J]. Cancer Manag Res, 2020, 12: 4789-4797. |
65 | ALVES MARTINS B A, DE BULHÕES G F, CAVALCANTI I N, et al. Biomarkers in colorectal cancer: the role of translational proteomics research[J]. Front Oncol, 2019, 9: 1284. |
66 | GONZALEZ-PONS M, CRUZ-CORREA M. Colorectal cancer biomarkers: where are we now?[J]. Biomed Res Int, 2015, 2015: 149014. |
67 | BAQAR A R, WILKINS S, STAPLES M, et al. The role of preoperative CEA in the management of colorectal cancer: a cohort study from two cancer centres[J]. Int J Surg, 2019, 64: 10-15. |
68 | KOULIS C, YAP R, ENGEL R, et al. Personalized medicine-current and emerging predictive and prognostic biomarkers in colorectal cancer[J]. Cancers (Basel), 2020, 12(4): 812. |
69 | BHARDWAJ M, WEIGL K, TIKK K, et al. Multiplex screening of 275 plasma protein biomarkers to identify a signature for early detection of colorectal cancer[J]. Mol Oncol, 2020, 14(1): 8-21. |
70 | DESMOND B J, DENNETT E R, DANIELSON K M. Circulating extracellular vesicle microrna as diagnostic biomarkers in early colorectal cancer-a review[J]. Cancers (Basel), 2019, 12(1): 52. |
71 | MOUSAVI S, MOALLEM R, HASSANIAN S M, et al. Tumor-derived exosomes: potential biomarkers and therapeutic target in the treatment of colorectal cancer[J]. J Cell Physiol, 2019, 234(8): 12422-12432. |
72 | YAN S, HAN B, GAO S, et al. Exosome-encapsulated microRNAs as circulating biomarkers for colorectal cancer[J]. Oncotarget, 2017, 8(36): 60149-60158. |
[1] | GONG Qiyu, CHEN Lei. Role of circulating and infiltrating B cells in immune microenvironment of colorectal cancer by multi-omics data profiling [J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(4): 472-481. |
[2] | Ying XU, Yi-min CHU, Da-ming YANG, Ji LI, Hai-qin ZHANG, Hai-xia PENG. Construction of a metastasis prediction model of microsatellite instability-high colorectal cancer based on differentially expressed gene assembly [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(9): 1197-1206. |
[3] | Zhu-ping QIAN, Yan YANG. Establishment and evaluation of screening model of minimal hepatic encephalopathy in patients with liver cirrhosis [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(9): 1228-1232. |
[4] | Yan-jie JI, Hao LUO, Hai-yan CAI, Xin-yu LIU, Shi-jia JIN, Shen-yue SU, Han-zhang XU, Hu LEI, Ying-li WU. Inhibition of CDDO-ME on ubiquitin-specific protease 2a activity and cell proliferation in triple negative breast cancer cells [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(8): 1025-1032. |
[5] | Rui LI, Yu-jie HAN, Lei ZHANG, Yu-jie TANG. Invitro screening and validation of novel targeted therapeutic strategy against diffuse intrinsic pontine glioma [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(8): 987-998. |
[6] | Wen-xia FU, Li-xiu CHEN, Jia-wei LE, Ruo-gu LI. Application of wearable dynamic electrocardiogram recorder to screening of atrial fibrillation [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(7): 926-930. |
[7] | Sheng CHENG, Yi ZHAO, Yong-chen WANG, Ping HUANG. Meta-analysis of the effect of BRAF gene mutation on the prognosis of colorectal cancer patients with liver metastases after hepatectomy [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(6): 786-792. |
[8] | Ru-juan BAO, Hui-fang CHEN, Yu DONG, You-qiong YE, Bing SU. Construction of prognostic risk score model of colorectal cancer gene signature based on transcriptome dysregulation [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(3): 285-296. |
[9] | Yan-ru MA, Lin-hua JI, Tian-ying TONG, Yu-qing YAN, Chao-qin SHEN, Xin-yu ZHANG, Ying-ying CAO, Jie HONG, Hao-yan CHEN. Establishment and validation of prognostic prediction model of colorectal cancer based on single-cell RNA sequencing [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(2): 159-165. |
[10] | Zhong-mao FU, Zai LUO, Ze-yin RONG, Jian-ming ZHANG, Teng-fei LI, Zhi-long YU, Chen HUANG. Study on the function and prognosis of circular RNA in colorectal cancer tissues based on high-throughput sequencing [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(2): 187-195. |
[11] | Wen-hui XU, Jing BIAN, Lei-zhen ZHENG. Research progress of the relationship between high-fat diet and colorectal cancer and its prevention and treatment countermeasures [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(11): 1514-1517. |
[12] | Zhi-ling CHEN, Chen LUO, Kang-jia ZHAO, Ling SHEN, San-lian HU. Application of two kinds of analgesia after colorectal cancer surgery: a meta-analysis [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2021, 41(10): 1344-1350. |
[13] | YAN Yu-qing, SHEN Chao-qin, CHEN Hao-yan, HONG Jie#, WANG Zhen-hua#. Expression of lnc-MTBP-5 in colorectal cancer and its effect on cell invasion [J]. JOURNAL OF SHANGHAI JIAOTONG UNIVERSITY (MEDICAL SCIENCE), 2020, 40(9): 1193-1201. |
[14] | SU Hang, MA Xiao-jing, YING Ling-wen, HE Xing-xing, ZHU Wei, TANG Jun-ling, WANG Yu-fei, BAO Yu-qian, ZHOU Jian. Efficiency comparison of fasting plasma glucose combined with 1,5-anhydroglucitol and combined with glycated albumin in diabetes mellitus screening [J]. , 2019, 39(9): 1077-. |
[15] | ZHANG Xin-tian, CHEN Jin-nan, WANG Qi-wen, LI Xiao-bo. Preliminary study on application of programmed cell death 1 ligand 2 to the diagnosis of colorectal cancer in confocal laser endomicroscopy [J]. , 2019, 39(8): 881-. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||